We are live on ! Find out more
GS

Gagnon Securities Portfolio holdings

AUM $519M Turnover 11.24%
1-Year Est. Return 44.91%
This Fund
S&P 500
This Quarter Est. Return
-6.04%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$673M
AUM Growth
-$31.2M
Cap. Flow
+$28.1M
Cap. Flow %
4.17%
Top 10 Hldgs %
41.71%
Holding
120
New
9
Increased
49
Reduced
35
Closed
8
Avg Time Held
2.7 years
Top 10 Avg Time Held
2.4 years
Top 20 Avg Time Held
2.7 years

Top Buys

Rank Stock Value
1
EVA icon
Enviva Inc.
EVA
+$13.9M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$10.4M
3
FRSH icon
Freshworks
FRSH
+$9.41M
4
WGS icon
GeneDx Holdings
WGS
+$6.85M
5
ZUO icon
Zuora, Inc.
ZUO
+$6.83M

Top Sells

Rank Stock Value
1
CMLFU
CM Life Sciences, Inc. Unit
CMLFU
+$10.3M
2
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$10.2M
3
AMRC icon
Ameresco
AMRC
+$7.52M
4
DVN icon
Devon Energy
DVN
+$6.26M
5
ONTO icon
Onto Innovation
ONTO
+$5.88M

Sector Composition

Rank Sector Weight
1 Healthcare 34.77%
2 Technology 29.5%
3 Industrials 12.25%
4 Consumer Discretionary 11.03%
5 Energy 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PFE icon
51
Pfizer
PFE
$168B
$1.46M 0.22%
33,957
– –
2016 Q1
22 quarters
NEX
52
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$1.39M 0.21%
302,179
+1,854
+0.6% +$7.46K
2017 Q1
18 quarters
SLG icon
53
SL Green Realty
SLG
$3.34B
$1.35M 0.2%
19,095
– –
2020 Q3
4 quarters
FLXN icon
54
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.29M 0.19%
211,141
+2,111
+1% +$13.2K
2017 Q3
16 quarters
ETWO.WS icon
55
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$1.28M 0.19%
440,906
+43,990
+11% +$132K
2021 Q2
1 quarter
HOLX icon
56
DELISTED
Hologic
HOLX
$1.1M 0.16%
+14,950
New +$1.12M
2021 Q3
0 quarters
OSUR icon
57
OraSure Technologies
OSUR
$263M
$993K 0.15%
+87,801
New +$964K
2021 Q3
0 quarters
DVN icon
58
Devon Energy
DVN
$54.2B
$962K 0.14%
27,096
-220,784
-89% -$6.26M
2021 Q1
2 quarters
TLMD
59
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$927K 0.14%
410,285
+557
+0.1% +$2K
2021 Q1
2 quarters
VIVO icon
60
DELISTED
Meridian Bioscience Inc
VIVO
$854K 0.13%
+44,361
New +$884K
2021 Q3
0 quarters
WLY icon
61
John Wiley & Sons Class A
WLY
$2.68B
$765K 0.11%
14,649
+1,253
+9% +$71.8K
2013 Q2
33 quarters
MRVL icon
62
Marvell Technology
MRVL
$217B
$763K 0.11%
12,650
-6,200
-33% -$372K
2019 Q1
10 quarters
URG icon
63
Ur-Energy
URG
$356M
$737K 0.11%
428,204
– –
2014 Q1
30 quarters
NVDA icon
64
NVIDIA
NVDA
$5.25T
$713K 0.11%
34,440
+440
+1% +$9.14K
2019 Q3
8 quarters
PYPL icon
65
PayPal
PYPL
$48.9B
$654K 0.1%
2,512
+20
+0.8% +$5.67K
2017 Q3
16 quarters
SLGCW
66
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$628K 0.09%
+182,095
New +$561K
2021 Q3
0 quarters
URNM icon
67
Sprott Uranium Miners ETF
URNM
$1.72B
$627K 0.09%
16,324
– –
2021 Q1
2 quarters
WFC icon
68
Wells Fargo
WFC
$248B
$606K 0.09%
13,056
– –
2021 Q1
2 quarters
EQC icon
69
DELISTED
Equity Commonwealth
EQC
$528K 0.08%
20,311
– –
2021 Q2
1 quarter
WGSWW
70
DELISTED
GeneDx Holdings Warrant
WGSWW
$521K 0.08%
245,973
+218,989
+812% +$720K
2021 Q2
1 quarter
PETS icon
71
PetMed Express
PETS
$26.4M
$520K 0.08%
19,365
– –
2021 Q1
2 quarters
WBA icon
72
DELISTED
Walgreens Boots Alliance
WBA
$517K 0.08%
10,997
– –
2020 Q3
4 quarters
DNN icon
73
Denison Mines
DNN
$2.14B
$516K 0.08%
351,064
– –
2017 Q2
17 quarters
GDRX icon
74
GoodRx Holdings
GDRX
$1.19B
$516K 0.08%
12,590
+54
+0.4% +$1.96K
2021 Q1
2 quarters
RRC icon
75
Range Resources
RRC
$9.68B
$501K 0.07%
22,157
– –
2018 Q1
14 quarters
1 2
3
4 5

Similar funds

WS
Wendel SE Paris $519M AUM 48.2% 1-Year Est. Return
MWC
MBM Wealth Consultants Chesterfield, Missouri $519M AUM 16.88% 1-Year Est. Return
MWM
Mindset Wealth Management Indianapolis, Indiana $519M AUM 46.03% 1-Year Est. Return
CFG
Compton Financial Group Towson, Maryland $519M AUM 14.76% 1-Year Est. Return
PDIP
Palo Duro Investment Partners Chicago, Illinois $518M AUM 22.62% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
SWM
Scissortail Wealth Management Tulsa, Oklahoma $520M AUM 21.73% 1-Year Est. Return

Gagnon Securities's Q3 2021 Portfolio in Review

As of Q3 2021, Gagnon Securities held 120 positions worth $673M, down 4.4% from $704M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Gagnon Securities deployed $28.1M of net new capital in Q3 2021, opening 9 new positions and adding to 49 existing holdings. Its largest new stake was Enviva Inc.: 258,297 shares worth $14M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Ameresco, an estimated $7.52M trimmed.

  • Gagnon Securities's largest Q3 2021 buy was Enviva Inc.: 258,297 shares worth $14M.
  • Gagnon Securities added most to GeneDx Holdings in Q3 2021, an estimated $6.85M increase.
  • Gagnon Securities's biggest Q3 2021 reduction was Ameresco, cutting an estimated $7.52M.
  • Gagnon Securities fully exited CM Life Sciences, Inc. Unit in Q3 2021, selling an estimated $10.3M.
  • Gagnon Securities's ten largest holdings make up 42% of its $673M portfolio in Q3 2021.
  • Gagnon Securities opened 9 new positions and closed 8 in Q3 2021.
  • Gagnon Securities's portfolio value fell 4.4% quarter-over-quarter to $673M.

Based on Gagnon Securities's 13F filing for Q3 2021, filed 12 Nov 2021.